Cheng Li

Stock Analyst at Oppenheimer

(1.28)
# 3,688
Out of 5,148 analysts
3
Total ratings
33.33%
Success rate
2.28%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Cheng Li

Wave Life Sciences
Dec 16, 2025
Maintains: Outperform
Price Target: $24$32
Current: $13.85
Upside: +131.05%
Vaxart
Aug 15, 2024
Initiates: Outperform
Price Target: $4
Current: $0.78
Upside: +415.69%